Literature DB >> 18045940

Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.

Susan Smyk-Pearson1, Ian A Tester, Jared Klarquist, Brent E Palmer, Jean-Michel Pawlotsky, Lucy Golden-Mason, Hugo R Rosen.   

Abstract

The mechanisms mediating protective immunity to hepatitis C virus (HCV) infection are incompletely understood because early infection in humans is rarely identified, particularly in those individuals who subsequently demonstrate spontaneous virus eradication. We have established a large national network of patients with acute HCV infection. Here, we comprehensively examined total HCV-specific CD4(+) and CD8(+) T-cell responses and identified functional T-cell thresholds that predict recovery. Interestingly, we found that the presence of HCV-specific cytotoxic T lymphocytes (CTLs) that can proliferate, exhibit cytotoxicity, and produce gamma interferon does not ensure recovery, but whether these CTLs were primed in the presence or absence of CD4(+) T-cell help (HCV-specific interleukin-2 production) is a critical determinant. These results have important implications for early prediction of the virologic outcome following acute HCV and for the development of novel immunotherapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045940      PMCID: PMC2258714          DOI: 10.1128/JVI.01581-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Secondary persistent infection with hepatitis C virus: a challenge for adaptive immunity.

Authors:  Michael Grant
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

2.  Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.

Authors:  Simona Urbani; Barbara Amadei; Paola Fisicaro; Daniela Tola; Alessandra Orlandini; Luca Sacchelli; Cristina Mori; Gabriele Missale; Carlo Ferrari
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

3.  Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.

Authors:  Hugo R Rosen; Camette Miner; Anna W Sasaki; David M Lewinsohn; Andrew J Conrad; Antony Bakke; H G Archie Bouwer; David J Hinrichs
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

4.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

5.  The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells.

Authors:  Sara E Hamilton; Monika C Wolkers; Stephen P Schoenberger; Stephen C Jameson
Journal:  Nat Immunol       Date:  2006-04-09       Impact factor: 25.606

6.  Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.

Authors:  Chia C Wang; Elizabeth Krantz; Jared Klarquist; Meighan Krows; Lanamarie McBride; Edward P Scott; Thomas Shaw-Stiffel; Scott J Weston; Hanne Thiede; Anna Wald; Hugo R Rosen
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

7.  Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.

Authors:  A Folgori; E Spada; M Pezzanera; L Ruggeri; A Mele; A R Garbuglia; M P Perrone; P Del Porto; E Piccolella; R Cortese; A Nicosia; A Vitelli
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

8.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

9.  CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.

Authors:  Z Lu; L Yuan; X Zhou; E Sotomayor; H I Levitsky; D M Pardoll
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  Determinants of viral clearance and persistence during acute hepatitis C virus infection.

Authors:  R Thimme; D Oldach; K M Chang; C Steiger; S C Ray; F V Chisari
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

View more
  43 in total

1.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.

Authors:  Rachael D Aubert; Alice O Kamphorst; Surojit Sarkar; Vaiva Vezys; Sang-Jun Ha; Daniel L Barber; Lilin Ye; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  CD4 T-cell immunotherapy for chronic viral infections and cancer.

Authors:  Alice O Kamphorst; Rafi Ahmed
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

Review 3.  Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Authors:  Juan-Ramón Larrubia; Elia Moreno-Cubero; Joaquín Miquel; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

4.  Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees.

Authors:  Iryna Zubkova; Hongying Duan; Frances Wells; Howard Mostowski; Esther Chang; Kathleen Pirollo; Kris Krawczynski; Robert Lanford; Marian Major
Journal:  Hepatology       Date:  2014-01-28       Impact factor: 17.425

5.  The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

Authors:  Eui-Cheol Shin; Su-Hyung Park; Michelina Nascimbeni; Marian Major; Laura Caggiari; Valli de Re; Stephen M Feinstone; Charles M Rice; Barbara Rehermann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 6.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

Review 7.  Progress in the development of vaccines for hepatitis C virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Zahra Meshkat
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  Rare birds in North America: acute hepatitis C cohorts.

Authors:  Andrea L Cox; Kimberly Page; Julie Bruneau; Naglaa H Shoukry; Georg M Lauer; Arthur Y Kim; Hugo R Rosen; Hank Radziewicz; Arash Grakoui; Daniel S Fierer; Andrea D Branch; David E Kaplan; Kyong-Mi Chang
Journal:  Gastroenterology       Date:  2008-12-04       Impact factor: 22.682

Review 9.  A new insight into hepatitis C vaccine development.

Authors:  Chun I Yu; Bor-Luen Chiang
Journal:  J Biomed Biotechnol       Date:  2010-06-13

10.  Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes.

Authors:  Hai-Chon Lee; Sung-Sang J Sung; Peter D Krueger; Yoon-Ah Jo; Hugo R Rosen; Steven F Ziegler; Young S Hahn
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.